← FDA DRUG APPROVALS

FDA ANDA · ANDA088116

MYFED

Sponsor: USL PHARMA

APPLICATION
ANDA088116
TYPE
ANDA
LATEST ACTION
1988-09-14
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

MYFEDDiscontinued
PSEUDOEPHEDRINE HYDROCHLORIDE 30MG/5ML, TRIPROLIDINE HYDROCHLORIDE 1.25MG/5ML · SYRUP · ORAL

Approval history

1988-09-14Manufacturing (CMC) · Supplement 18AP
1987-08-10Manufacturing (CMC) · Supplement 14AP
1987-08-10Manufacturing (CMC) · Supplement 13AP
1987-05-15Manufacturing (CMC) · Supplement 16AP
1987-05-15Manufacturing (CMC) · Supplement 15AP
1987-03-06Manufacturing (CMC) · Supplement 12AP
1984-12-07Manufacturing (CMC) · Supplement 9AP
1984-12-07Manufacturing (CMC) · Supplement 5AP
1984-12-07Manufacturing (CMC) · Supplement 10AP
1984-02-08Manufacturing (CMC) · Supplement 6AP
1983-11-07Manufacturing (CMC) · Supplement 3AP
1983-11-07Manufacturing (CMC) · Supplement 4AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →